Scarica l'app Stockscreener
5.32
5.72%
0.25
Precedente Chiudi:
$5.07
Aprire:
$5.01
Volume 24 ore:
123.89K
Relative Volume:
0.94
Capitalizzazione di mercato:
$202.47M
Reddito:
-
Utile/perdita netta:
$-27.66M
Rapporto P/E:
-5.60
EPS:
-0.95
Flusso di cassa netto:
$-24.36M
1 W Prestazione:
+18.06%
1M Prestazione:
+35.70%
6M Prestazione:
+117.89%
1 anno Prestazione:
+105.36%
Intervallo 1D:
$5.01
$5.50
Intervallo di 1 settimana:
$4.51
$5.7231
Portata 52W:
$1.9875
$5.885
Genelux Corp Stock (GNLX) Company Profile
Nome
Genelux Corp
Settore
Industria
Telefono
805-267-9889
Indirizzo
2625 TOWNSGATE ROAD, SUITE 230, WESTLAKE VILLAGE
Confronta GNLX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GNLX
Genelux Corp
|
5.36 | 191.51M | 0 | -27.66M | -24.36M | -0.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.18 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
471.48 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
552.36 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
808.25 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
331.09 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Genelux Corp Stock (GNLX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-10-29 | Iniziato | Guggenheim | Buy |
| 2024-08-28 | Iniziato | ROTH MKM | Buy |
| 2023-11-27 | Iniziato | H.C. Wainwright | Buy |
| 2023-09-12 | Iniziato | Maxim Group | Buy |
| 2023-02-15 | Iniziato | The Benchmark Company | Speculative Buy |
Genelux Corp Borsa (GNLX) Ultime notizie
Visual trend scoring systems applied to Genelux Corporation2025 Technical Overview & Low Drawdown Investment Strategies - newser.com
What’s next for Genelux Corporation stock priceTrade Signal Summary & Free Safe Capital Growth Stock Tips - newser.com
Genelux (NASDAQ:GNLX) Given Sell (E+) Rating at Weiss Ratings - MarketBeat
Applying chart zones and confluence areas to Genelux CorporationWeekly Stock Recap & AI Enhanced Market Trend Forecasts - newser.com
Is Genelux (NASDAQ:GNLX) In A Good Position To Invest In Growth? - Yahoo Finance
Can Genelux Corporation stock outperform in 2025 bull market2025 Technical Patterns & Risk Controlled Daily Trade Plans - newser.com
Market reaction to Genelux Corporation’s recent newsTrade Ideas & Long-Term Investment Growth Plans - newser.com
How Genelux Corporation stock performs in rate cut cyclesJuly 2025 Reactions & High Yield Stock Recommendations - newser.com
Published on: 2025-10-03 04:03:28 - newser.com
Genelux Corporation $GNLX Shares Bought by Woodward Diversified Capital LLC - MarketBeat
Is Genelux Corporation stock a buy before product launches2025 Top Gainers & Technical Confirmation Trade Alerts - newser.com
Is this a good reentry point in Genelux CorporationJuly 2025 Reactions & Breakout Confirmation Trade Signals - newser.com
Goldman Sachs Group Inc. Buys Shares of 88,463 Genelux Corporation $GNLX - Defense World
Will Genelux Corporation continue its uptrendJuly 2025 EndofMonth & Pattern Based Trade Signal System - newser.com
What drives Genelux Corporation stock priceStop Loss Placement Tips & Achieve Consistent Profits - earlytimes.in
Will Upcoming Readouts Push Genelux Toward A Broader Therapeutic Role? - RTTNews
Real time scanner hits for Genelux Corporation explainedRate Cut & Weekly High Potential Stock Alerts - newser.com
Whale Trades: Is Genelux Corporation showing insider buying2025 Earnings Surprises & Weekly High Return Stock Opportunities - خودرو بانک
Relative strength of Genelux Corporation in sector analysisJuly 2025 Snapshot & Consistent Income Trade Recommendations - newser.com
Tick level data insight on Genelux Corporation volatilityMarket Movement Recap & Daily Chart Pattern Signal Reports - newser.com
Retail Trends: Does Genelux Corporation stock reflect fundamentals2025 Retail Activity & AI Driven Stock Reports - khodrobank.com
Analyzing Genelux Corporation with multi timeframe chartsGap Up & Real-Time Buy Signal Alerts - newser.com
Real time pattern detection on Genelux Corporation stockChart Signals & AI Enhanced Market Trend Forecasts - newser.com
Key metrics from Genelux Corporation’s quarterly dataWeekly Trade Summary & Free AI Powered Buy and Sell Recommendations - newser.com
Ranking Genelux Corporation among high performing stocks via toolsJuly 2025 Spike Watch & Weekly Market Pulse Alerts - newser.com
How to read the order book for Genelux CorporationFed Meeting & High Accuracy Swing Entry Alerts - newser.com
Pullback Watch: Is Genelux Corporation a cyclical or defensive stockGold Moves & Risk Managed Investment Entry Signals - khodrobank.com
Bull Bear: Is Perspective Therapeutics Inc part of any major index2025 Short Interest & Risk Controlled Stock Pick Alerts - خودرو بانک
Is Genelux Corporation stock reversal real or fakeJobs Report & Expert Curated Trade Setups - newser.com
Aug Closing: Is Genelux Corporation trading at a discountJobs Report & Verified Momentum Stock Alerts - khodrobank.com
Measuring Genelux Corporation’s beta against major indicesMarket Risk Analysis & AI Driven Price Predictions - newser.com
Genelux Corporation’s volatility index tracking explainedWeekly Stock Recap & AI Driven Price Predictions - newser.com
Key resistance and support levels for Genelux CorporationWeekly Trading Summary & Safe Entry Momentum Stock Tips - newser.com
Published on: 2025-09-16 21:46:32 - newser.com
Can you recover from losses in Genelux CorporationMarket Movement Recap & Risk Controlled Stock Alerts - newser.com
Technical Analysis: Can Enlightify Inc stock outperform in a bear marketJuly 2025 Macro Moves & Fast Momentum Stock Entry Tips - خودرو بانک
Real time breakdown of Genelux Corporation stock performanceQuarterly Portfolio Summary & AI Based Buy and Sell Signals - newser.com
Genelux Corp Azioni (GNLX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Genelux Corp Azioni (GNLX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Zindrick Thomas | President and CEO |
May 12 '25 |
Sale |
2.92 |
10,764 |
31,431 |
191,447 |
| Yu Yong | VP, Clinical Trial Operations |
May 12 '25 |
Sale |
2.92 |
5,579 |
16,291 |
47,640 |
| Cappello Joseph | VP, Pharmaceutical Development |
May 12 '25 |
Sale |
2.92 |
4,737 |
13,832 |
52,266 |
| Smalling Ralph | Head of Regulatory |
May 12 '25 |
Sale |
2.92 |
1,259 |
3,676 |
34,760 |
| Tyree James L | Director |
Dec 30 '24 |
Sale |
2.46 |
3,460 |
8,512 |
45,791 |
0.86%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):